Moreover, epigenetic modifications associated with EZH2 contribute to the regulation of subsets of immune cells, including various T cells (3, 4), innate immune cells such as tumor-associated macrophages (TAMs) (5), myeloid-derived suppressor cells (6), NK cells (7), and so on. The gene discussed is EZH2; the disease is neoplasm.